Search the Newsreel

Motilal Oswal Financial Services posts Q1FY27 earnings call audio online

Brainsway Ltd|Price:15.970|Chg%:-0.540

Brainsway Ltd (BWAY) is an Israel-based company specializing in medical devices for neurological and psychopathological disorders. The company's primary product is the Transcranial Magnetic Stimulation (TMS) system, which non-invasively stimulates deep brain structures for various clinical applications, including major depressive disorders and obsessive-compulsive disorder. …

Volkswagen (XTRA:VOW3) Could Be 35% Undervalued After Weak Earnings

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Why Volkswagen Stock Is Back in Focus After Its Latest Earnings Volkswagen (XTRA:VOW3) has …

Zacks Names Brainsway (NASDAQ: BWAY) Bull Of The Day While Lululemon (NASDAQ: LULU) Earns Bear Designation

Zacks Equity Research has named Brainsway (NASDAQ: BWAY) its Bull of the Day due to strong revenue growth, expanding insurance coverage for its Deep TMS therapy, and a positive outlook for future earnings. Conversely, Lululemon (NASDAQ: LULU) received the Bear of the Day designation …

Volkswagen (XTRA:VOW3) Stock Looks Cheap After It Cut Sales Forecast

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Volkswagen stock has had a difficult run over the past few years, yet the current market multiples and a strong overall value score suggest the …

Brainsway Ltd (BWAY) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for Brainsway Ltd (BWAY), indicating a current valuation score of 5.10, ranking it 192 out of 200 in the Healthcare Equipment & Supplies industry. It highlights the company's current P/E ratio of 34.82, noting its position relative to …

H.C. Wainwright Maintains Brainsway(BWAY.US) With Buy Rating, Maintains Target Price $17

H.C. Wainwright has reiterated its Buy rating for Brainsway (BWAY.US), maintaining a target price of $17. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance and valuation. The decision reflects confidence in Brainsway's financial prospects and market position.

Brainsway (NASDAQ:BWAY) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen has downgraded Brainsway (NASDAQ:BWAY) from "buy" to "hold," despite other brokerages maintaining bullish ratings. The company still holds a consensus "Buy" rating with an average target price of $15.67 from analysts, and recently surpassed earnings expectations. Brainsway, a medical device company, …

Volkswagen (XTRA:VOW3) Cuts Revenue Outlook As Chinese Competition In Europe Builds

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Volkswagen (XTRA:VOW3) has reduced its full year revenue outlook. The company highlighted increasing competitive pressure from Chinese automakers in Europe. Management described the current auto industry backdrop …

Swarmer Promotes Garrett Kasper to CCO, Realigns Duties Among Executives

AUSTIN, Texas, July 24, 2026 (GLOBE NEWSWIRE) -- Swarmer, Inc (Nasdaq: SWMR) ("Swarmer" or the "Company"), a drone autonomy software company whose technology has supported more than 100,000 real-world combat missions in Ukraine since April 2024, today announced a promotion and realignment of duties …

Yesway, Inc. Revenue Breakdown – NASDAQ:YSWY

Volkswagen engineers charged with insider trading tied to Rivian joint venture

The U.S. Department of Justice has charged two Volkswagen engineers with securities fraud for an alleged insider-trading scheme connected to the German automaker's joint venture with Rivian. The indictment, unsealed Friday by the U.S. District Attorney for the Southern District of New York, alleges …

Motilal Oswal Financial Services Limited Revenue Breakdown – NSE:MOTILALOFS

Achtung! VW cuts sales forecast as auto industry remains 'extremely challenging'

Volkswagen (VWAGY) cut its full-year revenue outlook on Friday, claiming the environment for the auto industry as a whole was "extremely challenging." The world's second-largest carmaker now expects 2026 sales revenue to be flat or down 3% compared to last year, down from a …

Volkswagen Cuts Full-Year Sales Outlook

This article first appeared on GuruFocus. Volkswagen (VWAGY) reported modest second-quarter revenue growth but lowered its full-year sales outlook after weaker vehicle deliveries weighed on the first half. Revenue rose 2% from a year earlier to 82.44 billion. However, the group sold 4 million …

H.C. Wainwright reiterates Brainsway stock rating on strategic investments By Investing.com

H.C. Wainwright reiterated a Buy rating and a $17.00 price target for Brainsway (NASDAQ:BWAY) following Brainsway's strategic minority equity investments in Radial Health and Sound Minds Behavioral. These investments are part of Brainsway's long-term plan to drive revenue and equity value. The company has …

Volkswagen Q2 Earnings Call Highlights

Key Points Interested in Volkswagen AG? Here are five stocks we like better. Volkswagen's first-half results weakened as deliveries fell 6% to 4.1 million vehicles and operating profit dropped 12% to €5.9 billion, with China remaining the biggest drag on performance. Revenue was broadly …

Volkswagen’s profits crash as crisis deepens

Volkswagen workers are resisting plans to cut a further 50,000 jobs - Jens SCHLÜTER / AFP via Getty Images Volkswagen's profits have crashed by a third as its boss warned the carmaker faced "unprecedented risk". Oliver Blume said a turnaround plan that could involve …

Bull of the Day: Brainsway (BWAY)

Brainsway (BWAY) is a medical device company treating mental health disorders from major depressive disorder and OCD to substance abuse and cigarette addiction. Its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform uses a rapidly changing magnetic field to induce a small electrical current …

Volkswagen Aktie im Tief: Deutlich weniger Gewinn im Q2 & Stellenabbau kündigen sich an 🚗

Motilal Oswal Q1FY27 Results: Treasury Gains Lift Profit, But Weak Core Performance Sends Stock Down Over 9%

Volkswagen VZ unter Druck nach Q2-Enttäuschung: Profit enttäuscht, Ums

Motilal Oswal Financial Services Shares Fall 8% Even As Firm Swings To Profit

Volkswagen profit plunges as carmaker weighs mass job cuts

Beleaguered VW has been suffering from slimmer margins from electric cars, US tariffs and intense Chinese competition (Tobias SCHWARZ) Volkswagen said Friday that its net profit plunged in the second quarter as the crisis-hit carmaker, weighing up to 100,000 job cuts worldwide, grapples with …

Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable

Price-Driven Insight from (BWAY) for Rule-Based Strategy

This article provides a price-driven analysis for Brainsway Ltd. (NASDAQ: BWAY), highlighting strong near and mid-term sentiment, resistance testing, and an exceptional risk-reward short setup. It details three AI-generated institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop loss …

Kingsway Financial Services (NYSE:KWY) Shares Down 3.4% - Here's Why

QuantumScape Q2 Earnings Call Highlights

Key Points Interested in QuantumScape Corporation? Here are five stocks we like better. QuantumScape said it advanced automotive commercialization in Q2, highlighted by a new multi-year partnership with Honda and an updated arrangement with Volkswagen's PowerCo that keeps the long-term commercialization goals intact. The …

Oswal Greentech Share Price Forecast: 3 Year Outlook to 2030

Oswal Pumps Share Price Forecast: 3 Year Outlook to 2030

BTIG Initiates Brainsway(BWAY.US) With Buy Rating, Announces Target Price $18

BTIG has initiated coverage on Brainsway (BWAY.US) with a Buy rating. The firm has set a target price of $18 for the company's shares. This initiation signals analyst confidence in Brainsway's future performance.

BrainsWay Ltd (BWAY) Stock Up 4.9% but GF Value Says Overvalued -- GF Score: 65/100

BrainsWay Ltd (BWAY) shares rose 4.9% to $16.53, a significant increase year-to-date and over the past year. However, GuruFocus's GF Value™ indicates the stock is 138.2% overvalued at this price, suggesting a lack of margin of safety. While its GF Score™ of 65/100 (Above …

BrainsWay Announces Strategic Investment in Radial Health, Inc.

BrainsWay has invested $3 million in Radial Health, Inc., a management services organization that supports a network of Brain Medicine clinics. This minority equity investment is part of Radial's Series A financing and aims to expand access to advanced noninvasive mental health treatments like …

Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Given Consensus Rating of "Buy" by Analysts

Five analysts have issued a consensus "Buy" rating for Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY), with an average 12-month price target of $15.67. Recent analyst actions, including new coverage and upgrades, highlight positive sentiment. The company also surpassed Q1 earnings expectations, reporting an EPS of …

Brainsway (NASDAQ:BWAY) Coverage Initiated by Analysts at BTIG Research

BTIG Research has initiated coverage on Brainsway (NASDAQ:BWAY) with a "buy" rating and an $18 price target, indicating a 14.4% potential upside. This positive sentiment aligns with other recent analyst upgrades and the company's stronger-than-expected quarterly earnings, which surpassed estimates for both EPS and …

BrainsWay (NASDAQ: BWAY) makes $3M strategic bet on Radial Health

BrainsWay Ltd. announced a $3 million minority equity investment in Radial Health, Inc., a management services organization that supports a network of Brain Medicine clinics. This strategic investment is part of Radial's Series A financing and aligns with BrainsWay's strategy to expand awareness and …